TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bringaker Biofrakt AS
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
1,264
|
921 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
129
|
189 | |
| Total assets |
686
|
671 | |
| Current assets |
284
|
221 | |
| Current liabilities |
206
|
272 | |
| Equity capital |
440
|
358 | |
| - share capital |
45
|
47 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
64.1%
|
53.4% | |
| Turnover per employee | |||
| Profit as a percentage of turnover |
10.2%
|
20.5% | |
| Return on assets (ROA) |
18.8%
|
28.2% | |
| Current ratio |
137.9%
|
81.2% | |
| Return on equity (ROE) |
29.3%
|
52.8% | |
| Change turnover |
390
|
115 | |
| Change turnover % |
12%
|
45%
|
14% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.